Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler

Share this content:
Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler
Orbital Cellulitis Reported After Use of Facial Soft-Tissue Filler

TUESDAY, Feb. 14, 2017 (HealthDay News) -- Delayed and recurrent orbital cellulitis following use of facial soft-tissue filler is described in a case report published online Feb. 10 in Clinical & Experimental Ophthalmology.

Paul Ikgan Sia, M.B.Ch.B., from the Royal Adelaide Hospital in Australia, and colleagues describe the case of a 49-year-old female who presented with 12 months of recurrent left cheek inflammation that did not resolve with six courses of antibiotics. She described a thickened, indurated, and erythematous area in her left cheek, which became worse after subcutaneous triamcinolone injection into the affected area. The extraocular movements on the left were significantly restricted on examination.

The researchers identified two orbital abscesses on magnetic resonance imaging, which were incised and drained, with subsequent recovery. Two months later the patient presented with a relapse of orbital cellulitis. On surgical exploration, a permanent left cheek cable suture was identified; gelatinous material was present at the inferior end of the suture. On further postoperative questioning, the patient confirmed having had nasojugal fold or lower cheek permanent soft-tissue filler injection and cheek-lifting cable sutures inserted six years earlier. The gelatinous material was confirmed as permanent silicone filler. The patient recovered and was free of recurrence at 12-months follow-up.

"Although orbital complications from soft-tissue fillers are very rare, they can be potentially sight-threatening," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »